Onyx Liquid Embolic System
FDA premarket approval P030004/S020 · decided 2019-07-24
Approval details
- PMA number
- P030004
- Supplement
- S020
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Onyx Liquid Embolic System
- Generic name
- Agent, injectable, embolic
- Applicant
- Ev3 Neurovascular
- Date received
- 2019-06-26
- Decision date
- 2019-07-24
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- MFE
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- Change to the Biological Indicator (BI) Bacillus atrophaeus STN 062MG that is used in the dry heat sterilization of the Onyx Liquid Embolic System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| MERIDIAN GUIDEWIRE (K093681) | Ev3 Neurovascular | 2010-01-26 |
| HYPERGLIDE OCCLUSION BALLOON SYSTEM, HYPERFORM OCCLUSION BALLOON SYSTEM, MODEL 104-4112, 104-4113, 104-4127,104-4132,104 (K091458) | Ev3 Neurovascular | 2009-10-15 |
| HYPERGLIDE OCCLUSION BALLOON SYSTEM, MODEL 104-4310, 104-4315 (K092495) | Ev3 Neurovascular | 2009-09-22 |